Literature DB >> 20002024

Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports.

Friedrich Martin Wurst1, Natasha Thon, Steina Aradottir, Susanne Hartmann, Gerhard Adam Wiesbeck, Otto Lesch, Katrin Skala, Manfred Wolfersdorf, Wolfgang Weinmann, Christer Alling.   

Abstract

Phosphatidylethanol (PEth) is a direct ethanol metabolite, and has recently attracted attention as biomarker of ethanol intake. The aims of the current study are: (1) to characterize the normalization time of PEth in larger samples than previously conducted; (2) to elucidate potential gender differences; and (3) to report the correlation of PEth with other biomarkers and self-reported alcohol consumption. Fifty-seven alcohol-dependent patients (ICD 10 F 10.25; 9 females, 48 males) entering medical detoxification at three study sites were enrolled. The study sample was comprised of 48 males and 9 females, with mean age 43.5. Mean gamma glutamyl transpeptidase (GGT) was 209.61 U/l, average mean corpuscular volume (MCV) was 97.35 fl, mean carbohydrate deficient transferrin (%CDT) was 8.68, and mean total ethanol intake in the last 7 days was 1653 g. PEth was measured in heparinized whole blood with a high-pressure liquid chromatography method, while GGT, MCV and %CDT were measured using routine methods. PEth levels at day 1 of detoxification ranged between 0.63 and 26.95 micromol/l (6.22 mean, 4.70 median, SD 4.97). There were no false negatives at day 1. Sensitivities for the other biomarkers were 40.4% for MCV, 73.1% for GGT and 69.2% for %CDT, respectively. No gender differences were found for PEth levels at any time point. Our data suggest that PEth is (1) a suitable intermediate term marker of ethanol intake in both sexes; and (2) sensitivity is extraordinary high in alcohol dependent patients. The results add further evidence to the data that suggest that PEth has potential as a candidate for a sensitive and specific biomarker, which reflects longer-lasting intake of higher amounts of alcohol and seemingly has the above mentioned certain advantages over traditional biomarkers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20002024     DOI: 10.1111/j.1369-1600.2009.00185.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  38 in total

1.  Levels and types of alcohol biomarkers in DUI and clinic samples for estimating workplace alcohol problems.

Authors:  Paul R Marques
Journal:  Drug Test Anal       Date:  2012-02-06       Impact factor: 3.345

2.  Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol use.

Authors:  Michael G McDonell; Jordan Skalisky; Emily Leickly; Michael F Orr; Sterling McPherson; John Roll; Nathalie Hill-Kapturczak; Martin Javors
Journal:  Psychol Addict Behav       Date:  2017-07-17

3.  Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking.

Authors:  Yan Wang; Xinguang Chen; Judith A Hahn; Babette Brumback; Zhi Zhou; Maria J Miguez; Robert L Cook
Journal:  Alcohol Clin Exp Res       Date:  2017-12-05       Impact factor: 3.455

4.  Phosphatidylethanol Detects Moderate-to-Heavy Alcohol Use in Liver Transplant Recipients.

Authors:  Michael Francis Fleming; Matthew J Smith; Erika Oslakovic; Michael R Lucey; Jenny X Vue; Patrice Al-Saden; Josh Levitsky
Journal:  Alcohol Clin Exp Res       Date:  2017-03-20       Impact factor: 3.455

5.  Phosphatidylethanol (PEth) as a Biomarker of Alcohol Consumption in HIV-Infected Young Russian Women: Comparison to Self-Report Assessments of Alcohol Use.

Authors:  Andrew K Littlefield; Jennifer L Brown; Ralph J DiClemente; Polina Safonova; Jessica M Sales; Eve S Rose; Nikolay Belyakov; Vadim V Rassokhin
Journal:  AIDS Behav       Date:  2017-07

6.  Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.

Authors:  Scott H Stewart; David G Koch; Ira R Willner; Raymond F Anton; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2014-05-21       Impact factor: 3.455

Review 7.  Biomarkers for detection of alcohol consumption in liver transplantation.

Authors:  Katharina Staufer; Michel Yegles
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

Review 8.  [What ethanol metabolites as biological markers tell us about alcohol use].

Authors:  Friedrich Martin Wurst; Natasha Thon; Wolfgang Weinmann; Michel Yegles; Ulrich Preuss
Journal:  Wien Med Wochenschr       Date:  2013-12-10

9.  The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.

Authors:  Ludmila N Bakhireva; Renate D Savich; Dennis W Raisch; Sandra Cano; Robert D Annett; Lawrence Leeman; Mahek Garg; Chelsea Goff; Daniel D Savage
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

Review 10.  Protein biomarkers of alcohol abuse.

Authors:  Mariana P Torrente; Willard M Freeman; Kent E Vrana
Journal:  Expert Rev Proteomics       Date:  2012-08       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.